Breakthrough Cancer Vaccine Technology Reveals New Approach to Reprogram Tumor Environment

IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025 - IO Biotech (NASDAQ:IOBT)

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co-founders, Mads Hald Andersen, DMSc, PhD, Director of the National Center for Cancer Immune Therapy (CCIT-DK), chaired and presented at an educational session on cancer vaccines at the 2025 American Association…

In 2015 he creates the first breast cancer vaccine. The distinguished Greek woman of the Diaspora, Vaso Apostolopoulou, who as a child wanted to stop the scourge of the century, was honored days ago for her research work. The foreign professor and researcher described to ERT3 the feelings she received from the award of the international prize “Galien Scientific Research”, received by the hand of the Greek Prime Minister, Kyriakos Mitsotakis, and…

Breakthrough Cancer Vaccine Technology Reveals New Approach to Reprogram Tumor Environment

Latest data shows innovative dual-mechanism vaccine targets both tumor cells and immune suppressive cells. Revolutionary TME reprogramming approach revealed. Get details.